@article{e9ca8a9d28b64da9bb41290545645e9e,
title = "Navigating the regulatory road to approval for cancer gene therapies",
author = "Libutti, {S. K.}",
note = "Funding Information: We thank the Andalusian Platform of Bioinformatics (PAB; University of M{\'a}laga) for providing access to IPA software. This work was supported by the Instituto de Salud Carlos III/FEDER (PI10/00449 to PM, CP11/00024—Miguet Servet Program—to RRo and RTICC RD12/0036/0015); the Junta de Andaluc{\'i}a/FEDER (P08-CTS-3678 to PM), the MINECO (Fondo Especial del Estado para Dinamizaci{\'o}n de la Econom{\'i}a y Empleo PLE-2009-0111 to PM and SAF2010-15106 to MLT), The Spanish Association Against Cancer (Junta Provincial de Albacete-CI110023 to PM and Junta Provincial de Granada to RRo), Health Canada (H4084-112281 to PM, RRo and MR-M) and Obra Social Cajastur-IUOPA. RRu was supported by a fellowship of the ISCIII/FEDER. ",
year = "2015",
month = dec,
doi = "10.1038/cgt.2015.62",
language = "English (US)",
volume = "22",
pages = "553",
journal = "Cancer gene therapy",
issn = "0929-1903",
publisher = "Nature Publishing Group",
number = "12",
}
